Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.

Ultra is a technology and data company that develops skin health solutions. It develops Violet App, an application that measures and sends real-time alerts about UV exposure. It also monitors its users’ natural vitamin D production and recommends when to use sunscreen. Ultra offers Violet Plus, a smart device that sends alerts about UV exposure. Ultra was founded by Nabyl Bennouri, Nattapon Chaimanonart, and Jie Lian in 2014. It is headquartered in Portland, Oregon.

Medical Need Europe AB is a self financed and privately owned company. The headquarters are located right in the center of Stockholm, Sweden and the company is incorporated under Swedish law. In Stockholm central functions like medical affairs, logistics, regulatory affairs, pharmacovigilance, customer service, partnership development, marketing, management and finance is located. Our mission is to provide niche pharmaceuticals for patients with special needs or for specific situations in health care. We aim to satisfy unmet medical needs for patients and caregivers in Europe. We strive to offer high quality services for the benefit of both patients, customers, payers and partners to meet their needs and secure access to smaller specialty products for patients with rare disorders.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Develops prescription drugs for mild to moderate pain relief

Dermavant Sciences GmbH, a subsidiary of Roivant Sciences Ltd., is a company headquartered in Basel, Switzerland. The firm develops and commercializes therapeutics in medical dermatology.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Alpha & Omega Semiconductor, Inc. designs, develops and supplies power semiconductor products. It offers portable computers, flat panel televisions, smart phones, battery packs, consumer and industrial motor controls and power supplies for computers, servers and telecommunications equipment. The firm's major products include power discrete and integrated circuits. Alpha & Omega Semiconductor was founded in 2000 by Mike F. Chang, Yueh-Se Ho and Anup Bhalla and is headquartered in Sunnyvale, CA.

The chemical treatment market is being actively used by the firm. Tumor, cardiovascular and cerebrovascular, women and children, and other therapeutic regions will be included for biological pharmaceuticals, chemical drug imitations, new research and development, and other collaboration and layout methods. In the future, Yibai plans to grow its pharmaceutical manufacturer, consolidate its major pharmaceutical industry, and build two new sources of growth for biological and chemical pharmaceuticals based on traditional Chinese medicine.

Alpha and Omega Semiconductor Limited, or AOS, is a designer, developer and global supplier of a broad range of power semiconductors, including a wide portfolio of Power MOSFET, IGBT and Power IC products. AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables us to introduce innovative products to address the increasingly complex power requirements of advanced electronics. AOS differentiates itself by integrating its Discrete and IC semiconductor process technology, product design, and advanced packaging know-how to develop high performance power management solutions. AOS's portfolio of products targets high-volume applications, including portable computers, flat panel TVs, LED lighting, smart phones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment

Pharmigene is established in 2005 and funded by venture capital firms and individuals. Their goal is to innovate and commercialize diagnostic tests that enable individuals to be better informed about their genomic makeup and to make decisions that better their health. We have licensed exclusive world-wide rights and transferred key know-how from Academia Sinica relating to the genetic markers that are associated with adverse drug reactions caused by several popular drugs. We have obtained ISO 13485 / 9001 and GMP certifications, and are manufacturing our DNA genetic tests under the most stringent guideline. In developing our DNA genetic tests, we also have validated our tests with clinical studies that involved hundreds and thousands of patients. Today our DNA genetic tests are available world wide. Specifically several of our tests have obtained IVD clearance from Department of Health in Taiwan.

Part of Canon, Inc., Toshiba Medical Systems Co. Ltd. is a Malaysian company located in Penang that develops and manufactures digital imaging and scanning technologies to the medical sector.